The clinical trial packaging market will grow from USD 3.62 billion in 2025 to USD 9.12 billion by 2034, at a CAGR of 10.80% during the forecast period.
Strategic and Recent Development in Clinical Trial Packaging Industry
- In April 2025, In Changsha, Hunan Province, on April 18, 2025, LakeShore Biopharma Co., Ltd. hosted the 2025 CO "Contract Sales Organization" Annual Meeting and the presentation of the new packaging solution (liquid medication transfer device) for the YSJA rabies vaccine (Vero cell). By addressing important safety issues in vaccine administration, the new formulation, which regulatory bodies approved for lot release on April 15, 2025, will start widespread distribution in China in a matter of weeks. In order to solve issues such needle tip pain, compounding contamination, and medical staff occupational exposure, the unique packaging YSJA vaccine has been improved.
| Schreiner MediPharm |
Packaging and functional label solutions for the healthcare industry |
| Headquartered |
Germany, Europe |
| Recent Development |
In April 2024, Schreiner MediPharm unveiled the launch of the late-stage customization capabilities for its Radio-Frequency IDentification (RFID)-Labels series allowing sophisticated smart labels to be supplied on short notice and order-specific programming of the integrated RFID chip. |
Clinical Trial Packaging Market Companies
Become a valued research partner with us, please feel free to contact us at sales@towardspackaging.com
